Description
QoR vs NRG Academy in Valorant’s VCL North America Stage 2 Swiss Stage Group Stage is a best-of-three matchup scheduled for March 26 at 7:00PM ET. Outcomes resolve to QoR or NRG Academy based on the match winner; ties or unplayed status resolve to 50-50. If a forfeit or walkover occurs, the survivor wins unless a complete forfeit makes it 50-50; final results rely on vlr.gg, with credible reporting if vlr.gg is delayed beyond two hours after play concludes.
Event stats
Market highlights
Related events
Markets
Outcome | Odds | Spread | 24h Change | 24h Volume | Total Volume | Liquidity | |
|---|---|---|---|---|---|---|---|
| Match Winner | NRG Academy | — | — | — | — | — | |
| Map 1 Winner | QoR | — | — | — | — | — | |
| Map 2 Winner | NRG Academy | — | — | — | — | — | |
| O/U 2.5 Games | Over | — | — | — | — | — | |
| Map Handicap: QoR (-1.5) vs NRG Academy (+1.5) | NRG Academy | — | — | — | — | — |
Rules
This market refers to the Valorant Round 2 match between QoR and NRG Academy in the VCL North America: Stage 2 Swiss Stage Group Stage, initially scheduled for March 26 at 7:00PM ET. This market will resolve to "QoR" if QoR win the match against NRG Academy. This market will resolve to "NRG Academy" if NRG Academy win the match against QoR. If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50. If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins. If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50. The resolution source for this market will be official information from https://vlr.gg. However, if https://vlr.gg has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.